Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.
Yu X, Li W, Deng Q, You S, Liu H, Peng S, Liu X, Lu J, Luo X, Yang L, Tang M, Weng X, Yi W, Liu W, Wu S, Ding Z, Feng T, Zhou J, Fan J, Bode AM, Dong Z, Liu J, Cao Y.
Yu X, et al. Among authors: bode am.
Mol Carcinog. 2017 May;56(5):1414-1426. doi: 10.1002/mc.22602.
Mol Carcinog. 2017.
PMID: 27996164